Segment Name Product Name  
  • New Dermatology Products registered in Thailand.
    [February 2015]
  • New ACTDs filed, 5 more to be filed by year end In Thailand.
    [February 2015]
  • Anxiset approved by THAI FDA.
    [June 2014]
  • ANxiset now available in Thai market. [June 2014]
  • Obsurge enters Urology segment with URISURGE & URISURGE-D.
  • To strengthen our base in the market of anti-inflammatory, Obsurge successfully launched Seradic Plus tablet.
  • Launch of AMSURGE-AT(Amlodipine+Atenolol) @ Rs1.40 /tab[Feb 2013]
  • Obsurge enters Cardiac and Diabetic Segment with 11 Products[Feb 2013]
  • NACTAB(N-Acetylcystine) for female infertility launched [Jan 2012]
  • Muscodol-P launched [1st Nov 2011]
  • ACTD for Anxiset Filed in Thailand [Nov 2011]
  • ACTD for NOR-STERON(Northiesterone 5mg) filed in Thailand [Oct 2011]
  • Spl P-grade amoxy incorporated in production of Duciclav-625 tab for better stability [Apr 2011]
  • Anxiset Plus and Anxiset E launched [Apr 2011]
Welcome to our Website

In 2002, a group of spirited pharma professionals with varied experience in finance, marketing, sales , production, & distribution joined hands to start an organization with a vision to provide relief from the scourge of disease at an affordable price to the widest possible cross-section of patients in the country. The organization has identified the therapy gaps and bridged it with unique formulations fitting squarely into the gaps. After the initial hiccups the organization is now well set to make rapid strides in the post GATT scenario with a bold presence through new launches which have great potential for sales. The organization is headed by a seasoned personality Mr. J.S. Chauhan ,Who is the C.M.D. of the organization, a person with extensive experience in pharma sales & marketing, production & finance. In the organization quality systems are well defined processes. Any aberration is mapped against the correct process to check for non compliance. If processes are inadequate, they are rejiggered and standards are reset. Gap Analysis, taking into accounts both internal & external context of competitive environment, forms the basis of strategizing for the future. Business excellence is achieved through leadership in Customer focus & satisfaction , Strategic Planning, Process Management & Information Analysis. Excesses This has always been a beckon light paradigm for the company .

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player